HRT Financial’s Array Biopharma Inc ARRY Stock Holding History

HRT Financial’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-17,886	Closed	-$128K	–	211
2015 Q2	$128K	Buy	+17,886	New	+$132K	0.06%	146

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

HRT Financial's ARRY Position: Q3 2015 in Review

HRT Financial sold out of Array Biopharma Inc (ARRY) in Q3 2015, closing a stake of 17,886 shares — an estimated $128K sold.

HRT Financial first reported a position in ARRY in Q2 2015 and held it in 1 quarter. The position peaked at $128K in Q2 2015. 157 funds tracked by Wall St. Rank hold ARRY as of Q3 2015.

HRT Financial reported no remaining Array Biopharma Inc position as of Q3 2015 after selling out during the quarter.
HRT Financial sold 17,886 Array Biopharma Inc shares in Q3 2015, an estimated $128K.
HRT Financial first reported a position in Array Biopharma Inc in Q2 2015 and held it in 1 quarter.
HRT Financial's Array Biopharma Inc position peaked at $128K in Q2 2015.
157 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2015.

Based on HRT Financial's 13F filing for Q3 2015, filed 12 Nov 2015.